MARKETS
S&P 5007,811.5+0.59%
NASDAQ 10030,883.1+0.51%
DOW 3051,655.0+0.83%
NIKKEI 22569,030.9-0.02%
DAX25,087.3+1.13%
FTSE 10010,552.1+1.06%
Equities

Viavi EVP Sells 30% of His Stake After a 216% Run

Paul McNab cut his direct Viavi stake by 30%, selling 11,032 shares for $429,917 after a 216% one-year run in the shares. What the filing does and does not tell investors.

Jack Sorensen 6 min read
A dimly lit electronics lab featuring oscilloscopes and equipment on desks, creating a technical atmosphere.

Viavi Solutions executive vice president Paul McNab sold 11,032 shares for $429,917, about 30% of his direct holdings, leaving him with 25,639 shares worth close to $1 million after a 216% one-year rally in the stock.

An executive vice president at Viavi Solutions (VIAV) has taken money off the table after one of the sharper runs in the network test and optical instruments business. Paul McNab sold 11,032 shares for $429,917, a disposal that accounted for roughly 30% of his direct holdings, according to the transaction detailed by Motley Fool. He is left with 25,639 shares, a position worth close to $1 million.

The sale lands against a backdrop that explains the timing without requiring any interpretation of intent: Viavi shares have surged 216% over the past year. Executives whose compensation is weighted toward equity routinely face a concentration problem after a move of that size, and trimming is the standard answer.

What the filing actually discloses

Three numbers carry the story. The gross proceeds were $429,917. The share count sold was 11,032. The residual direct stake is 25,639 shares. Because the sale is described as 30% of his prior direct holdings, the arithmetic implies a pre-sale position of roughly 36,671 shares — consistent with adding the sold block back to the remaining one. On an illustrative basis, dividing the proceeds by the shares sold works out to an average of about $38.97 per share, which sits within the range the stock has traded in recently.

What the filing does not disclose is motive. Insider sales get read as signals far more often than they deserve to be. A single executive-level disposal, even one that cuts a direct stake by nearly a third, is a weak indicator on its own. Diversification, tax planning, the exercise and immediate sale of options, and pre-arranged trading plans all produce identical-looking filings. The one thing the disclosure does establish cleanly is that McNab remains a shareholder with roughly seven figures of exposure to the same stock — the sale reduced his bet, it did not close it.

The 216% rally is the context that matters

A stock that has more than tripled over twelve months changes the math for everyone holding it, insiders included. For an executive, the equity portion of a pay package that was sized at one price becomes a materially larger share of personal net worth at a much higher one. Selling 30% after a 216% advance still leaves the remaining position worth far more, in dollar terms, than the entire holding was worth before the run began.

That is the frame investors should apply. The question is not whether an insider sold; it is whether the operating story that drove the rally is intact. Viavi's business sits in network testing, measurement and optical technology — the equipment and instruments used to build out and verify communications infrastructure. Demand in that category tends to track carrier and data-center capital spending cycles, which have been the dominant source of upside across the communications-equipment supply chain.

Where the shares closed

Viavi last traded at 38.75, up 3.61% on the session, against a previous close of 37.40 and an intraday range of 38.00 to 39.73, as of the last trade on Friday, 11 September 2026. Markets are closed; that is the most recent print, not a live quote.

The move outpaced the broad market on the day. The S&P 500 tracker (SPY) closed at $764.29, up 0.85%. The Nasdaq 100 proxy (QQQ) finished at $714.88, up 0.87%, and the Dow tracker (DIA) ended at $525.79, up 0.97%. Viavi's gain was roughly four times the index moves, which is characteristic of a stock in a momentum phase: it amplifies the tape in both directions.

Viavi's gain was roughly four times the index moves, which is characteristic of a stock in a momentum phase: it amplifies the tape in both directions.

Applying the last close to the residual stake, 25,639 shares are worth on the order of $993,500 — the "nearly $1 million" figure in the disclosure, shown here as an illustrative calculation rather than a reported valuation.

How to read insider sales without overreading them

A few practical rules apply to filings like this one:

  • Size relative to the remaining stake matters more than the dollar amount. A $429,917 sale sounds large in isolation; as 30% of a position, with the balance still held, it reads as trimming rather than exit.
  • Clusters beat singles. One executive selling into strength tells you little. Several officers and directors selling within a short window is a pattern worth noting. Nothing in this disclosure establishes such a cluster.
  • Direction of the stock before the sale is the first thing to check. After a 216% advance, selling is the statistically ordinary behaviour, not the anomaly.
  • Buying is the stronger signal. Executives sell for many reasons and buy for essentially one.

What to watch next

The follow-through questions are about the business, not the filing. Whether Viavi's order book keeps pace with the spending cycle that lifted the shares; whether margins hold as volume scales; and whether the valuation the market has assigned after a triple can be supported by reported results rather than by expectations of them. Momentum stocks reprice quickly when the earnings cadence disappoints, and a 3.61% single-session gain in a name that has run 216% is a reminder of how much daily volatility is now embedded in the shares.

For shareholders, the practical takeaway is unglamorous. An insider reduced concentration after an exceptional run and kept a stake worth roughly $1 million. That is a portfolio decision, not a forecast. The forecast still has to come from the numbers Viavi reports next.

Key facts

  • Shares sold / proceeds: 11,032 shares for $429,917
  • Share of prior direct stake: 30%; 25,639 shares retained, worth nearly $1 million
  • VIAV last close: 38.75, +3.61% (as of 11 Sep 2026, 20:00 GMT)
  • One-year share move: +216%

Frequently asked questions

How many Viavi shares did Paul McNab sell and for how much?

Paul McNab, an executive vice president at Viavi Solutions, sold 11,032 shares for gross proceeds of $429,917. The disposal represented approximately 30% of his prior direct holdings in the company. After the transaction he continued to hold 25,639 shares directly, a stake described in the filing as worth close to $1 million.

Does this sale mean the executive has lost confidence in Viavi?

The filing does not state a reason, and a single sale is a weak signal. McNab retained 25,639 shares, roughly 70% of his prior direct stake, worth close to $1 million. Executives commonly trim holdings after large share-price gains for diversification, tax or pre-arranged plan reasons, none of which imply a negative view of the business.

How much has Viavi stock risen recently?

Viavi shares have surged 216% over the past twelve months. The stock last closed at 38.75, up 3.61% on the day from a previous close of 37.40, with a session range of 38.00 to 39.73, as of the last trade on Friday, 11 September 2026. That daily gain outpaced the major US index trackers.

What price did the shares sell at on average?

The disclosure gives total proceeds of $429,917 for 11,032 shares. Dividing one by the other implies an average of roughly $38.97 per share, an illustrative calculation rather than a reported execution price. That level sits within the range the stock has traded in around its most recent close of 38.75.

What was McNab's stake before the sale?

Because the 11,032 shares sold are described as about 30% of his prior direct holdings, and 25,639 shares remain, the implied pre-sale direct position was roughly 36,671 shares. That figure is derived from the disclosed numbers rather than stated separately in the filing, and covers direct holdings only.

How did the broad market perform on the same session?

On the last trading session before this report, the S&P 500 tracker SPY closed at $764.29, up 0.85%. The Nasdaq 100 proxy QQQ finished at $714.88, up 0.87%, and the Dow tracker DIA ended at $525.79, up 0.97%. Viavi's 3.61% gain was well ahead of all three.

Sources

Photo: khezez | خزاز · Pexels Licence — source

Filed under Equities

More on Equities

See all →